{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:34:41Z","timestamp":1792690481477,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sepsis remains a leading cause of preventable death, partly because its rapidly evolving and heterogeneous biology has often been treated as a uniform inflammatory syndrome in therapeutic development and clinical trials. This narrative review synthesizes recent advances in human immune profiling to reframe sepsis as an inflammation-driven immune reprogramming disorder characterized by time-resolved trajectories and biologically defined subtypes, in which hyperinflammation and low-response programs can arise in parallel and shift across compartments. We summarize core mechanisms linking early innate sensing, endothelial injury, coagulation\u2013inflammation coupling, and cytokine network \u201cinstruction\u201d to later immune paralysis, lymphocyte loss, functional exhaustion, and the chronic critical illness phenotype. We then translate these concepts into a practical interpretive framework for dynamic immune monitoring, emphasizing trends and composite signals over single biomarkers, and highlighting how misalignment of patient state, therapeutic direction, and timing helps explain past trial failures. Finally, we outline implications for next-generation interventions and study designs, arguing for bidirectional, time-stamped immunomodulation guided by repeated phenotyping, enriched enrollment, and endpoints that capture secondary infections, organ recovery trajectories, and longer-term functional outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1887033","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:21:38Z","timestamp":1783570898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammation-driven immune reprogramming in sepsis: from cytokine storm to immunoparalysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Sha","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Adult Critical Care Medicine, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"He","sequence":"additional","affiliation":[{"name":"Department of Adult Critical Care Medicine, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2403213","article-title":"Sepsis and septic shock","volume":"391","author":"Meyer","year":"2024","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00468-X","article-title":"Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies","volume":"12","author":"Shankar-Hari","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01722-8","article-title":"A pairwise cytokine code explains the organism-wide response to sepsis","volume":"25","author":"Takahama","year":"2024","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.11.052","article-title":"Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities","volume":"132","author":"Chadda","year":"2024","journal-title":"Br J Anaesth"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0752-4","article-title":"An immune-cell signature of bacterial sepsis","volume":"26","author":"Reyes","year":"2020","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01490-5","article-title":"Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis","volume":"24","author":"Kwok","year":"2023","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40779-023-00462-y","article-title":"Single-cell transcriptome profiling of sepsis identifies HLA-DRlowS100Ahigh monocytes with immunosuppressive function","volume":"10","author":"Yao","year":"2023","journal-title":"Mil Med Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12967-023-04631-4","article-title":"Deciphering the molecular and cellular atlas of immune cells in septic patients with different bacterial infections","volume":"21","author":"Sun","year":"2023","journal-title":"J Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00330-2","article-title":"Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine","volume":"12","author":"Cajander","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1130214","article-title":"Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis","volume":"14","author":"Joshi","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1696914","article-title":"Decoding immune low-response states in sepsis: single-cell and 3D spatial transcriptomic insights into immunoparalysis","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq4433","article-title":"An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression","volume":"14","author":"Cano-Gamez","year":"2022","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03956-5","article-title":"A consensus immune dysregulation framework for sepsis and critical illnesses","volume":"31","author":"Moore","year":"2025","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03964-5","article-title":"A consensus blood transcriptomic framework for sepsis","volume":"31","author":"Scicluna","year":"2025","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067251","article-title":"ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol","volume":"12","author":"Kotsaki","year":"2022","journal-title":"BMJ Open"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104363","article-title":"Immunopathophysiology of human sepsis","volume":"86","author":"Wiersinga","year":"2022","journal-title":"EBioMedicine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.624279","article-title":"Immune deregulation in sepsis and septic shock: reversing immune paralysis by targeting PD-1\/PD-L1 pathway","volume":"11","author":"Nakamori","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","article-title":"Immune dysregulation in sepsis: experiences, lessons and perspectives","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discov"},{"key":"B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40560-025-00802-1","article-title":"Molecular endotypes in sepsis: integration of multicohort transcriptomics based on RNA sequencing","volume":"13","author":"Mekata","year":"2025","journal-title":"J Intensive Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300171","article-title":"The calm after the storm: implications of sepsis immunoparalysis on host immunity","volume":"211","author":"Silva","year":"2023","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1682306","article-title":"Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction","volume":"16","author":"Vella","year":"2025","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08110-w","article-title":"Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 cases","volume":"51","author":"Monneret","year":"2025","journal-title":"Intensive Care Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1393283","article-title":"Endotoxin tolerance and trained immunity: breaking down immunological memory barriers","volume":"15","author":"L\u00f3pez-Collazo","year":"2024","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41419-023-05656-9","article-title":"Epigenetic mechanisms of immune remodeling in sepsis: targeting histone modification","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113894","article-title":"Altered DNA methylation underlies monocyte dysregulation and immune exhaustion memory in sepsis","volume":"43","author":"Caldwell","year":"2024","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.11.6952","article-title":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans","volume":"166","author":"Hotchkiss","year":"2001","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13054-024-05099-4","article-title":"Lymphopenia in sepsis: a narrative review","volume":"28","author":"Wang","year":"2024","journal-title":"Crit Care"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/cc13176","article-title":"Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis","volume":"18","author":"Chang","year":"2014","journal-title":"Crit Care"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1323797","article-title":"The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1029438","article-title":"Role of regulation of PD-1 and PD-L1 expression in sepsis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s40001-024-02203-w","article-title":"Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression","volume":"29","author":"Luo","year":"2024","journal-title":"Eur J Med Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000004087","article-title":"The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later","volume":"95","author":"Efron","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010191","article-title":"Persistent inflammation, immunosuppression and catabolism syndrome (PICS) after polytrauma: a rare syndrome with major consequences","volume":"9","author":"Hesselink","year":"2020","journal-title":"J Clin Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005067","article-title":"Biomarker evidence of the persistent inflammation, immunosuppression and catabolism syndrome (PICS) in chronic critical illness (CCI) after surgical sepsis","volume":"274","author":"Darden","year":"2021","journal-title":"Ann Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100569","DOI":"10.1016\/j.medj.2024.12.003","article-title":"Immune-cell signatures of persistent inflammation, immunosuppression, and catabolism syndrome after sepsis","volume":"6","author":"Sun","year":"2025","journal-title":"Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s43856-024-00542-7","article-title":"Sepsis endotypes identified by host gene expression across global cohorts","volume":"4","author":"Chenoweth","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101829","article-title":"Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial response","volume":"5","author":"Brandes-Leibovitz","year":"2024","journal-title":"Cell Rep Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/cc10069","article-title":"Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis","volume":"15","author":"Heininger","year":"2011","journal-title":"Crit Care"},{"key":"B42","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13054-018-2261-0","article-title":"Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study","volume":"22","author":"van de Groep","year":"2018","journal-title":"Crit Care"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07562-w","article-title":"Herpes simplex virus and cytomegalovirus lung reactivations in severe COVID-19 patients: to treat or not to treat? That is (still) the question","volume":"50","author":"Luyt","year":"2024","journal-title":"Intensive Care Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13613-024-01377-0","article-title":"Organ crosstalk and dysfunction in sepsis","volume":"14","author":"Borges","year":"2024","journal-title":"Ann Intensive Care"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaf001","article-title":"Recent advances of precision immunotherapy in sepsis","volume":"13","author":"Arapis","year":"2025","journal-title":"Burns Trauma"},{"key":"B46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13613-025-01524-1","article-title":"Biomarkers to guide sepsis management","volume":"15","author":"Bourika","year":"2025","journal-title":"Ann Intensive Care"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1498974","article-title":"Time-dependent variation in immunoparalysis biomarkers among patients with sepsis and critical illness","volume":"15","author":"Samuelsen","year":"2024","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70109","article-title":"Sepsis: the evolution of molecular pathogenesis concepts and clinical management","volume":"6","author":"Feng","year":"2025","journal-title":"MedComm (2020)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13054-024-04964-6","article-title":"Towards personalized medicine: a scoping review of immunotherapy in sepsis","volume":"28","author":"Slim","year":"2024","journal-title":"Crit Care"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2025.2505537","article-title":"Biomarker guided immunomodulatory precision medicine to improve prognostic, predictive and adaptive enrichment strategies in sepsis trials","volume":"25","author":"Alevizou","year":"2025","journal-title":"Expert Rev Mol Diagn"},{"key":"B51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13613-025-01534-z","article-title":"IFN\u03b3 in human sepsis: a scoping review","volume":"15","author":"Thomas-R\u00fcddel","year":"2025","journal-title":"Ann Intensive Care"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1887033\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:21:39Z","timestamp":1783570899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1887033\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2026.1887033"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1887033","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1887033"}}